This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sarepta Therapeutics Inc (SRPT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 256.96M 187.66M 39.90M 33.59M
Receivables 3.53M 4.71M 3.63M 3.22M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 3.06M 1.53M 1.65M 1.02M
Total Current Assets 270.81M 193.91M 45.18M 37.84M
Property, Plant & Equipment, Gross 32.38M 20.10M 20.03M 19.00M
Accumulated Depreciation & Depletion 17.33M 16.71M 15.76M 14.96M
Property, Plant & Equipment, Net 15.05M 3.40M 4.26M 4.04M
Intangibles 5.04M 4.91M 4.76M 3.98M
Other Non-Current Assets 672.00K 2.78M 155.00K 123.00K
Total Non-Current Assets 20.76M 11.08M 9.18M 8.14M
Liabilities & Shareholder Equity
Total Assets 291.57M 204.99M 54.37M 45.98M
Accounts Payable 17.63M 7.53M 9.40M 1.31M
Short Term Debt 92.00K 89.00K 85.00K 81.00K
Other Current Liabilities 9.89M 65.22M 5.57M 39.15M
Total Current Liabilities 35.97M 78.89M 20.60M 45.86M
Long Term Debt 1.58M 1.67M 1.76M 1.84M
Deferred Income Taxes 6.84M 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 760.00K 993.00K 1.09M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 8.41M 2.43M 2.75M 2.94M
Total Liabilities 44.38M 81.31M 23.35M 48.79M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 247.19M 123.68M 31.02M -2.82M
Common Par 4.00K 3.00K 13.00K 11.00K
Additional Paid In Capital 790.42M 554.93M 340.97M 304.82M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -543.24M -431.25M -309.96M -307.65M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 248.77M 125.35M 32.77M -975.00K
Total Equity 247.19M 123.68M 31.02M -2.82M
Total Liabilities & Stock Equity 291.57M 204.99M 54.37M 45.98M
Total Common Shares Outstanding 37.75M 31.70M 22.62M 18.73M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 33.85M 23.60M 21.60M 18.54M
Diluted Weighted Shares Outstanding 33.85M 23.60M 21.60M 18.54M
Number of Employees 146 103 98 98
Number of Part-Time Employees 0 0 0 0
SRPT News

SRPT Sarepta Therapeutics Inc

Analysts Ratings for SRPT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 5
Moderate Buy 2 2 2 2
Hold 5 5 5 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET SRPT ANALYST REPORT

Brokerage Partners

SRPT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs